XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Interim Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Research and development, net $ (1,459) $ (1,169)
General and administrative (1,562) (1,215)
Operating loss (3,021) (2,384)
Other income (see Note 3G) 316
Financing income, net 104 13
Net loss $ (2,601) $ (2,371)
Basic net loss per share $ (0.08) $ (0.17)
Diluted net loss per share $ (0.08) $ (0.17)
Basic weighted average common shares outstanding 31,085,606 14,055,973
Diluted weighted average common shares outstanding 31,085,606 14,055,973